Daryn Smith

1.5k total citations
64 papers, 1.1k citations indexed

About

Daryn Smith is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Daryn Smith has authored 64 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 24 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Daryn Smith's work include Prostate Cancer Treatment and Research (20 papers), Radiopharmaceutical Chemistry and Applications (10 papers) and Cancer Treatment and Pharmacology (10 papers). Daryn Smith is often cited by papers focused on Prostate Cancer Treatment and Research (20 papers), Radiopharmaceutical Chemistry and Applications (10 papers) and Cancer Treatment and Pharmacology (10 papers). Daryn Smith collaborates with scholars based in United States, Canada and United Kingdom. Daryn Smith's co-authors include Lance K. Heilbrun, Elisabeth I. Heath, Patricia LoRusso, Ulka N. Vaishampayan, Michael S. Simon, Philip A. Philip, Lawrence E. Flaherty, Cheryl A. Miree, Diane R. Brown and Wei Du and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Daryn Smith

62 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daryn Smith United States 20 327 321 293 175 164 64 1.1k
Weihong Zhao China 22 167 0.5× 521 1.6× 213 0.7× 194 1.1× 159 1.0× 84 1.7k
Marco Quaglia Italy 23 168 0.5× 333 1.0× 375 1.3× 90 0.5× 253 1.5× 96 1.8k
Ik Joo Chung South Korea 19 352 1.1× 416 1.3× 278 0.9× 232 1.3× 231 1.4× 57 1.4k
Frank S. Fan Taiwan 20 358 1.1× 256 0.8× 224 0.8× 117 0.7× 366 2.2× 84 1.4k
Étienne Lemarié France 16 355 1.1× 199 0.6× 526 1.8× 96 0.5× 222 1.4× 31 1.5k
Begoña de las Heras Spain 11 608 1.9× 318 1.0× 321 1.1× 149 0.9× 229 1.4× 27 1.8k
Lorraine Pelosof United States 16 694 2.1× 371 1.2× 299 1.0× 224 1.3× 161 1.0× 35 1.8k
Birgit Gathof Germany 23 172 0.5× 377 1.2× 131 0.4× 127 0.7× 151 0.9× 82 1.6k
Junshik Hong South Korea 25 685 2.1× 325 1.0× 498 1.7× 130 0.7× 182 1.1× 179 2.0k
Andrea J. Bernhardy United States 13 384 1.2× 796 2.5× 131 0.4× 64 0.4× 96 0.6× 17 2.2k

Countries citing papers authored by Daryn Smith

Since Specialization
Citations

This map shows the geographic impact of Daryn Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daryn Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daryn Smith more than expected).

Fields of papers citing papers by Daryn Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daryn Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daryn Smith. The network helps show where Daryn Smith may publish in the future.

Co-authorship network of co-authors of Daryn Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Daryn Smith. A scholar is included among the top collaborators of Daryn Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daryn Smith. Daryn Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heath, Elisabeth I., Archana Thakur, Wei Chen, et al.. (2024). Race-Related Differences in Sipuleucel-T Response among Men with Metastatic Castrate–Resistant Prostate Cancer. Cancer Research Communications. 4(7). 1715–1725. 3 indexed citations
2.
Ginsburg, Kevin, Adam Cole, Michael E. Silverman, et al.. (2019). Should all prostate needle biopsy Gleason score 4 + 4 = 8 prostate cancers be high risk? Implications for shared decision-making and patient counselling. Urologic Oncology Seminars and Original Investigations. 38(3). 78.e1–78.e6. 10 indexed citations
3.
Vaishampayan, Ulka N., Izabela Podgorski, Lance K. Heilbrun, et al.. (2018). Biomarkers and Bone Imaging Dynamics Associated with Clinical Outcomes of Oral Cabozantinib Therapy in Metastatic Castrate-Resistant Prostate Cancer. Clinical Cancer Research. 25(2). 652–662. 3 indexed citations
4.
Vaishampayan, Ulka N., Jawana M. Lawhorn‐Crews, Lance K. Heilbrun, et al.. (2017). A Pilot Trial Evaluating Zoledronic Acid Induced Changes in [18F]FMAU-Positron Emission Tomography Imaging of Bone Metastases in Prostate Cancer. Molecular Imaging and Biology. 19(6). 810–816. 2 indexed citations
5.
6.
Singareddy, Rajareddy, Louie Semaan, M. Katie Conley‐LaComb, et al.. (2013). Transcriptional Regulation of CXCR4 in Prostate Cancer: Significance of TMPRSS2-ERG Fusions. Molecular Cancer Research. 11(11). 1349–1361. 35 indexed citations
7.
Soubani, Ayman O., et al.. (2013). The outcome of cancer patients with acute respiratory distress syndrome. Journal of Critical Care. 29(1). 183.e7–183.e12. 25 indexed citations
8.
Vaishampayan, Ulka N., Joseph A. Fontana, Lance K. Heilbrun, et al.. (2013). Phase II trial of bevacizumab and satraplatin in docetaxel-pretreated metastatic castrate-resistant prostate cancer. Urologic Oncology Seminars and Original Investigations. 32(1). 31.e25–31.e33. 30 indexed citations
9.
Al‐Kadhimi, Zaid, Roberto Rodríguez, Wei Chen, et al.. (2012). Anti-Thymocyte Globulin (Thymoglobulin), Tacrolimus, and Sirolimus as Acute Graft-versus-Host Disease Prophylaxis for Unrelated Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 18(11). 1734–1744. 16 indexed citations
10.
Gupta, Sachin, Lance K. Heilbrun, Daryn Smith, et al.. (2011). Safety and efficacy of molecularly targeted agents in patients with metastatic kidney cancer with renal dysfunction. Anti-Cancer Drugs. 22(8). 794–800. 23 indexed citations
11.
Choi, Minsig, et al.. (2008). Retrospective review of cancer patients ≥80 years old treated with chemotherapy at a comprehensive cancer center. Critical Reviews in Oncology/Hematology. 67(3). 268–272. 5 indexed citations
12.
Schneider, Bryan J., Gregory P. Kalemkerian, Michael Kraut, et al.. (2008). Phase II Study of Celecoxib and Docetaxel in Non-small Cell Lung Cancer (NSCLC) Patients with Progression after Platinum-Based Therapy. Journal of Thoracic Oncology. 3(12). 1454–1459. 21 indexed citations
13.
Morris, Robert, Ronald D. Alvarez, Stephen Andrews, et al.. (2008). Topotecan weekly bolus chemotherapy for relapsed platinum-sensitive ovarian and peritoneal cancers. Gynecologic Oncology. 109(3). 346–352. 21 indexed citations
14.
Vaishampayan, Ulka N., et al.. (2007). Phase II trial of pegylated interferon and thalidomide in malignant metastatic melanoma. Anti-Cancer Drugs. 18(10). 1221–1226. 9 indexed citations
15.
Abidi, Muneer H., et al.. (2007). Non‐bacterial infections in allogeneic non‐myeloablative stem cell transplant recipients. Transplant Infectious Disease. 9(1). 3–10. 9 indexed citations
16.
El-Rayes, B. F., Camille S. Norton, Wael Sakr, et al.. (2005). Cellular DNA content parameters as prognostic indicators in human astrocytomas. Journal of Neuro-Oncology. 71(2). 85–89. 4 indexed citations
17.
Ibrahim, R., Roger Dansey, Muneer H. Abidi, et al.. (2005). Safety of low-dose low-molecular-weight-heparins in thrombocytopenic stem cell transplantation patients: a case series and review of the literature. Bone Marrow Transplantation. 35(11). 1071–1077. 27 indexed citations
18.
Djurić, Zora, et al.. (1998). Oxidative DNA Damage Levels in Blood from Women at High Risk for Breast Cancer are Associated with Dietary intakes of Meats, Vegetables, and Fruits. Journal of the American Dietetic Association. 98(5). 524–528. 47 indexed citations
19.
Simon, Michael S., et al.. (1996). Clinical surveillance for early stage breast cancer: An analysis of claims data. Breast Cancer Research and Treatment. 40(2). 119–128. 12 indexed citations
20.
Djurić, Zora, Lance K. Heilbrun, Michael S. Simon, et al.. (1996). Levels of 5‐hydroxymethyl‐2′‐deoxyuridine in DNA from blood as a marker of breast cancer. Cancer. 77(4). 691–696. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weihong Zhao Breakdown of academic impact, for papers by Marco Quaglia Breakdown of academic impact, for papers by Ik Joo Chung Breakdown of academic impact, for papers by Frank S. Fan Breakdown of academic impact, for papers by Étienne Lemarié Breakdown of academic impact, for papers by Begoña de las Heras Breakdown of academic impact, for papers by Lorraine Pelosof Breakdown of academic impact, for papers by Birgit Gathof Breakdown of academic impact, for papers by Junshik Hong Breakdown of academic impact, for papers by Andrea J. Bernhardy
Rankless by CCL
2026